Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial

<h4>Objectives</h4> <p>Early treatment of HIV-infected children and adults is important for optimal immune reconstitution. Infants’ immune systems are more plastic and dynamic than older children’s or adults’, and deserve particular attention. This study aimed to understand the re...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Lewis, J, Payne, H, Walker, A, Otwombe, K, Gibb, D, Babiker, A, Panchia, R, Cotton, M, Violari, A, Klein, N, Callard, R
Materialtyp:	Journal article
Publicerad:	Frontiers Media 2017

Liknande verk

Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children
av: Penelope C. Rose, et al.
Publicerad: (2022-06-01)

Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
av: Lewis, J, et al.
Publicerad: (2012)

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?
av: Steve Innes, et al.
Publicerad: (2014-01-01)

Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
av: De Rossi, A, et al.
Publicerad: (2005)

Cortical structural changes related to early antiretroviral therapy (ART) interruption in perinatally HIV-infected children at 5 years of age
av: Emmanuel C. Nwosu, et al.
Publicerad: (2021-06-01)

Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial
av: Helen Payne, et al.
Publicerad: (2021-09-01)

When to start antiretroviral therapy in infants and children
av: Mark F Cotton, et al.
Publicerad: (2009-12-01)

When should children with HIV infection be started on antiretroviral therapy?
av: Steven B Welch, et al.
Publicerad: (2008-03-01)

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
av: Picat, M, et al.
Publicerad: (2013)

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
av: Avy Violari, et al.
Publicerad: (2019-01-01)

6 Epigenetic dysregulation of the major histocompatibility complex (MHC) region in HIV-infected children on early antiretroviral therapy
av: Stephanie Shiau, et al.
Publicerad: (2017-07-01)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
av: Dubrocq G, et al.
Publicerad: (2018-06-01)

Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy
av: Leal Manuel, et al.
Publicerad: (2006-07-01)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
av: Gossez, M, et al.
Publicerad: (2018)

Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
av: De Rossi, A, et al.
Publicerad: (2002)

The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough?
av: Sulggi A. Lee, et al.
Publicerad: (2016-09-01)

Cases inefficient antiretroviral therapy for HIV-1 in children
av: Yu. V. Ostankova, et al.
Publicerad: (2017-06-01)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
av: Szubert, A, et al.
Publicerad: (2015)

Monitoring of highly active antiretroviral therapy in HIV infection.
av: Walker, A, et al.
Publicerad: (2011)

Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children.
av: Nikmah S Idris, et al.
Publicerad: (2016-01-01)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
av: Samual A. Garner, et al.
Publicerad: (2017-04-01)

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
av: V. B. Denisenko, et al.
Publicerad: (2018-07-01)

Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children
av: Patrícia El Beitune, et al.

Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA
av: Natella Rakhmanina, et al.
Publicerad: (2016-01-01)

Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion.
av: Tin Phan, et al.
Publicerad: (2024-07-01)

Correction: Association of Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children.
av: Iris Chen, et al.
Publicerad: (2013-01-01)

Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa.
av: Edward J Mills, et al.
Publicerad: (2013-01-01)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
av: Evelyn Y. Bonney, et al.
Publicerad: (2021-03-01)

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
av: Kasirye, P, et al.
Publicerad: (2012)

Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa
av: Lee Fairlie, et al.
Publicerad: (2022-08-01)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
av: Haberer, J, et al.
Publicerad: (2011)

Drug monitoring of antiretroviral drugs in children with perinatal HIV infection
av: A. Yu. Sambyalova, et al.
Publicerad: (2024-07-01)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
av: Foster, C, et al.
Publicerad: (2017)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
av: Musiime, V, et al.
Publicerad: (2014)

When to start antiretroviral therapy in HIV-infected children
av: Tammy Meyers
Publicerad: (2002-07-01)

Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy
av: Ana Cecília Montes Gil, et al.

Adherence and effectiveness of antiretroviral therapy in HIV infected children
av: K S Sanjay, et al.
Publicerad: (2016-01-01)

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
av: Gibb, D, et al.
Publicerad: (2002)

Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs
av: Carolina Herrera, et al.
Publicerad: (2021-03-01)

Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
av: De Rossi, A, et al.
Publicerad: (2002)